Vidyasagar Reddy Gantla

Author

Also Known As

Vidyasagar R. Gantla, Vidyasagar Reddy Gantla

Publications

120

Citations

H-Index

Concepts

All Affiliations

Vidyasagar Reddy Gantla is an author at Arisan Therapeutics (United States) specializing in drug discovery, medicine, and biomolecular engineering.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	68
2	Biomolecular Engineering	2	2	68
3	Pharmacology	2	2	68
4	Drug Discovery	2	2	68
5	Drug Development	1	1	54

Vidyasagar Reddy Gantla

Publications

112

Citations

H-Index

Page 1

	Year	Citations
Design and Synthesis of 5-Aryl-pyridone-carboxamides as Inhibitors of Anaplastic Lymphoma Kinase Rongshi Li, Liquan Xue, Tong Zhu, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryPharmaceutical ChemistryMedicineDrug Discovery	2006	54
Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors Michael Plewe, Vidyasagar Reddy Gantla, Eric Brown, ACS Medicinal Chemistry Letters	2020	22
Discovery of a novel highly potent broad-spectrum heterocyclic chemical series of arenavirus cell entry inhibitors Michael Plewe, Vidyasagar Reddy Gantla, Young-Jun Shin, Bioorganic & Medicinal Chemistry Letters MedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral Drug	2021	14
Potent inhibition of arenavirus infection by a novel fusion inhibitor Brian B. Gowen, Shibani Naik, Jonna B. Westover, Antiviral Research	2021	12
Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir Jonna B. Westover, Shibani Naik, Kevin W. Bailey, Antiviral Research	2022	10

Page 1